Compare international online pharmacies prices and services

Product Name: Erlotinib
Generic Name: Erlotinib
Common Brands: Tarceva
Pharmaceutical Categories: Cancer

Where to buy Erlotinib online:

Shop | Product | Forms | Strength | Conditions
  • Tarceva tablets 150 mg
  • 5% discount coupon: 5OFF
  • Payment: Visa, Mastercard, AmEx, Bitcoin, Tether (USDT)
  • Shipping: worldwide
  • Delivery: unregistered mail, trackable courier
  • Erlonat tablets 100 mg
  • Erlonat tablets 150 mg
  • 10% discount coupon: 918cc60b466a42ba
  • Payment: PayBis, Cryptocurrency, MG, WU, Zelle
  • Shipping: worldwide
  • Delivery: registered airmail, FedEx, DHL

  • Erlotinib (trade names include Tarceva, Erlocip, Erlonat, Zyceva) is an anti-cancer medication from protein kinase inhibitors pharmacological group. This medicine is used for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works as an epidermal growth factor receptor inhibitor (EGFR inhibitor).

    Tarceva (Erlotinib Hydrochloride) tablets 150 mg

    Customers also buy these medications from the same pharmacological classes:

  • Afatinib (Gilotrif)
  • Alectinib (Alecensa)
  • Cabozantinib (Cabometyx, Cometriq)
  • Crizotinib (Xalkori)
  • Dabrafenib (Tafinlar)
  • Entrectinib (Rozlytrek)
  • Everolimus (Zortress, Certican)
  • Icotinib (Conmana)
  • Imatinib (Gleevec)
  • Lapatinib (Tykerb, Tyverb)
  • Lenvatinib (Lenvima, Lenvanix)
  • Midostaurin (Rydapt)
  • Neratinib (Nerlynx)
  • Nilotinib (Tasigna)
  • Palbociclib (Ibrance)
  • Quizartinib (Vanflyta)
  • Ribociclib (Kisqali)
  • Ridaforolimus (Deforolimus)
  • Sorafenib (Nexavar)
  • Sunitinib (Sutent)

    Pharmaceutical and medical classifications:

  • Anti cancer drugs
  • Antineoplastic medicines
  • Cytostatic agents
  • Epidermal growth factor receptor tyrosine kinase (EGFR) inhibitors
  • NSCLC treatment medications
  • Oncological treatment
  • Pancreatic cancer therapy

    The Anatomical Therapeutic Chemical (ATC) classification system (developed by the World Health Organization):

  • L - Antineoplastic and immunomodulating agents
  • L01 - Antineoplastic agents
  • L01X - Other antineoplastic agents
  • L01XE - Protein kinase inhibitors
  • L01XE03 - Erlotinib

    Medical conditions for erlotinib in the International Statistical Classification of Diseases and Related Health Problems:

  • Malignant neoplasm of pancreas - C25
  • Malignant neoplasm of bronchus and lung - C34

    Pregnancy category:

  • C - Australia (Risk cannot be ruled out)
  • N - United States (Not classified yet)

    Forms of active pharmaceutical ingredients (APIs):

  • Erlotinib Base
  • Erlotinib Hydrochloride
  • Erlotinib Mesylate

    Chemical, international, and other names of this drug:

  • Erlotinibe
  • Erlotinibi
  • Erlotinibum
  • Erlotynib

    Most known trade names (brands and generics) worldwide:

  • Erlocip - Cipla
  • Erlonat - Natco Pharma
  • Erlotinib - Mylan
  • Tarceva - Roche, Astellas Pharma, Genentech, OSI Pharmaceuticals, Schwarz Pharma
  • Zyceva - Zydus pharmaceuticals

    References and external sources:

  • Erlotinib main article on Wikipedia:
  • Erlotinib compound on PubChem:
  • Erlotinib Hydrochloride compound on PubChem:
  • Erlotinib medicine on DrugBank:
  • Erlotinib Hydrochloride on DrugBank:
  • Erlotinib FAQ on MedlinePlus (revised 03/15/2017):
  • Tarceva (Erlotinib Hydrochloride) tablets drug label on DailyMed (revised December 12, 2018):
  • Shilpa Medicare Erlotinib Hydrochloride film-coated tablets drug label on DailyMed (revised October 25, 2019):
  • Tarceva (Erlotinib Hydrochloride) oral tablets official prescribing and patient counseling information from the U.S. FDA (revised 10/2016):
  • Tarceva (Erlotinib Hydrochloride) tablets for oral use prescribing and patient information from Genentech pharmaceutical company (revised 10/2016):
  • Tarceva (Erlotinib) tablets official website powered by Roche:
  • Tarceva (Erlotinib HCl) 25 mg, 100 mg, 150 mg film-coated tablets package information leaflet on (revised January 2022):
  • Erlocip (Erlotinib, Tarceva generic) 100 mg and 150 mg tablets prescribing information from Cipla pharmaceutical company (revised 16/06/2021):

    Revised: May 2022

  • Disclaimer: Please note, this website is not an online pharmacy, drugstore and related online pharma shop. It does not sell, supply or advertise any prescription and OTC drugs, medications, other goods and services. All reviews, links, lists, databases, texts, videos, images, and other content on the website are provided free and only for informational and educational purposes. Medical content on this website, including drug names, indications, contraindication, side effects, categories, classifications, forms, doses, prices, other health and pharmaceutical information are taken only from trusted and authoritative professional sources (see "References"), reviewed and prepared by our licensed experts, content inspectors and editors.
    You should always consult your doctor or other healthcare professional before using any medication. This website, our staff and support do not provide own medical instructions and advices.
    All brands and trade names appearing on the website are registered trademarks and intellectual property of their respective companies.
    Remember that buying drugs and medicines online is a responsibility only of customers, sellers and suppliers regarding existing legislation in their jurisdictions.

    Home | Sitemap | Privacy Policy | Cookies Policy | Terms of Service | References | Contact Us

    Copyright © 2007 - 2023 All rights reserved.